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Abstract
In this paper we propose a general class of gamma frailty transformation models for multivariate
survival data. The transformation class includes the commonly used proportional hazards and
proportional odds models. The proposed class also includes a family of cure rate models. Under an
improper prior for the parameters, we establish propriety of the posterior distribution. A novel
Gibbs sampling algorithm is developed for sampling from the observed data posterior distribution.
A simulation study is conducted to examine the properties of the proposed methodology. An
application to a data set from a cord blood transplantation study is also reported.
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1 Introduction
In the analysis of univariate censored survival data, the Cox proportional hazards model
(Cox, 1972) plays a prominent role. Even when more complex models are fit to a given data
set, the Cox model may often serve as a starting point. As an alternative, under the
proportional odds model (Bennett, 1983), there is proportionality between the odds
computed with different covariate values. However, in many situations, proportionality does
not seem to be a tenable assumption. To overcome such problems, many authors consider
linear models relating the covariates to some transformation of the survival function.
Transformation models for univariate survival data were studied by Cheng et al. (1995),
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Scharfstein et al. (1998), Kosorok et al. (2004), and Banerjee et al. (2007), among others.
The so-called generalized odds-rate hazards (GORH) models (Scharfstein et al., 1998)
contain as special cases both the proportional hazards and the proportional odds models.
In this paper, our goal is to carry out Bayesian inference for a class of gamma shared frailty
transformation models for multivariate survival data. Frailty models allow one to model the
association between survival times from subjects within subgroups. The correlation structure
for any pair of times is the same and depends on the frailty parameter. An account of
Bayesian methods for frailty models is provided by Ibrahim et al. (2001, Chapter 4). For
transformation models for multivariate survival data, we mention the recent work by Zeng &
Lin (2007) and Zeng et al. (2009) dealing with maximum likelihood estimation, whereas
Yin (2008) develops Bayesian inference for frailty cure rate models. Unlike Zeng & Lin
(2007) and Zeng et al. (2009), in our approach, the transformation parameters are estimated
within the Bayesian framework. Our paper follows the development of Zeng et al. (2009)
and can be also seen as a multivariate extension of the work by Banerjee et al. (2007). The
proposed model formulation is also quite different than the one of Yin (2008). Under the
proposed model, the frailty multiplies the transformed cumulative hazard function and, using
the Laplace transform, the marginal survival function is available in a closed form. Thus, as
a by-product, the closed form expression of the observed data likelihood function can be
easily derived, which facilitates convenient computation of Bayesian model selection criteria
such as the Deviance Information Criterion (DIC) (Spiegelhalter et al., 2002) and the
Conditional Predictive Ordinate (CPO) (Ibrahim et al., 2001, Chapter 6). In addition, the
proposed model formulation allows us to establish propriety of the posterior distribution
with improper priors for the model parameters under mild conditions and to obtain flexible
survival functions which can be improper or proper.
Multivariate survival models are quite useful in modeling patient and donor factors which
influence outcome in Hematopoietic Stem Cell Transplantation (HSCT), a common therapy
for leukemia. Joint modeling the effects of patient characteristics on outcomes such as the
time-to-relapse of the primary disease and the time-to-first-incidence of chronic graft-
versus-host disease (CGVHD), a major complication of HSCT, is of clinical interest. In this
paper, we illustrate the proposed methodology using a dataset of 859 patients reported in
Ballen et al. (2012).
The remainder of the paper is organized as follows. Section 2 is dedicated to the formulation
of the model. The prior distribution is specified and the propriety of the posterior
distribution is established in Section 3. In Appendix B, we present the full conditional
distributions for the Gibbs sampler. Properties of the proposed methodology are assessed
through a simulation study conducted in Section 4. In Section 5, we present an illustrative
example using a dataset from a cord blood transplantation study. Some general concluding
remarks are given in Section 6.
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2.1 The model formulation and likelihood function
Let Tik denote the failure time of an event of type k for the i-th subject, for k = 1, …, K and i
= 1, …, n. We assume that the study ends at some finite τ. Let wi, i = 1, …, n be unobserved
independent frailty variables, which follow a gamma distribution (G) with parameters (1/θ,
1/θ), where θ > 0 is the variance of wi. We assume that Ti1, …, TiK are independent
conditional on wi. For the gamma frailty model, some dependence measures are presented in
Hougaard (2000, Section 7.3). For example, Kendall’s τ and the median concordance are
given by 1/(1 + 2/θ) and 4(2θ+1 − 1)−1/θ − 1, respectively. We consider the transformation
Gk(υ) = log(1 + rk υ)/rk if rk > 0 and Gk(υ) = υ if rk = 0, where rk ≥ 0 is the transformation
parameter. Banerjee et al. (2007), Yin (2008) and Zeng et al. (2009) discuss some properties
of this transformation, which are not repeated here.
Let xi denote a p × 1 vector of covariates which does not include an intercept. Given wi, we
assume that the cumulative hazard function for Tik is given by
(1)
where Hk(·) is a cumulative baseline hazard function and βk = (βk1, …, βkp)′ denotes the
regression coefficient vector, k = 1, …, K. For rk → 0, Gk(υ) = υ, which is the identity
transformation, and if rk = 1, we obtain Gk(υ) = log(1+υ). With these two special cases, we
recover the well-known proportional hazards (PH) and proportional odds (PO) models,
respectively. When 0 < rk < 1 or rk > 1, the model does not have an interpretation as clear as
the PH and PO models.
Under the specification in (1), the conditional survival function and density function are
given, respectively, by
(2)
and , where hk(t) is the baseline
hazard function such that .
Let Cik denote the censoring time. We assume that Cik is independent of Tik and wi given the
covariates xi. We observe yik = min(Tik, Cik) and νik = I(Tik ≤ Cik), where νik is the failure
indicator such that νik = 1 if yik is a failure time and νik = 0 if yik is right censored.
Henceforth, Dc = (n, K, y, X, ν, w) denotes the complete data, where y = (y1, …, yn)′, yi =
(yi1, …, yiK)′, i = 1, …, n, are independent, X is the n×p matrix of covariates with i-th row
, w = (w1, …, wn)′ and ν follows the notation for y. The complete data likelihood function
is given by
(3)
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As an additional assumption, the baseline hazard function hk(·) is represented by a piecewise
function. First, we construct K sets of finite partitions of the time axis with cut points 0 = sk0
< sk1 < ⋯ < sk,Jk−1 < sk,Jk, where sk,Jk−1 = max(yik : νik = 1) and sk,Jk = τ, that is, sk,Jk−1 is
the maximum failure time, k = 1, …, K. In the results reported in Sections 4 and 5, for j = 1,
…, Jk − 1, we chose the intervals (sk,j−1, sk,j] with approximately the same number of failure
times (choice based on the percentiles of the failure times). In the first Jk − 1 intervals, we
specify a constant hazard λkj, whereas in the last interval, we assume an exponential decay
hazard function λkJk e
−(t−sk,Jk−1) so that the cumulative hazard function is bounded (we will
return to this point in Section 2.2). The choice of sk,Jk−1 implies that no failures occur in the
last interval, meaning that the jumps in the baseline hazard function (λk1, …, λk,Jk−1)
correspond to the failure times. The form of the hazard function in the last interval can be
different from exponential decay. We also define an interval indicator δikj such that δikj = 1
if for the k-th event type, the i-th subject failed or was censored in the j-th interval, and δikj =
0 otherwise. Therefore, from (3), it follows that
(4)
After integrating out w in (4) with respect to the density π(w∣θ), we obtain the likelihood
function for the observed data Do = (n, K, y, X, ν) as
(5)
where , i = 1, …, n.
The piecewise specification for the baseline hazard function can accomodate different
shapes of the underlying hazard function. The degree of complexity of the model
represented by (5) is controlled by the number of intervals Jk. The larger the number of
intervals, the more complex the model is. In practice, we suggest doing analyses for some
values of (J1, …, JK) in order to assess the sensitivity of the posterior estimates. Moreover,
the selection of (J1, …, JK) may be guided by measures of model adequacy as we discuss in
Sections 4 and 5.
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In many clinical and epidemiological studies, there are subjects who are not susceptible to
the occurrence of the event of interest. The proportion of such subjects is often called the
cure rate or cure fraction. Models for survival data with a cure rate, also known as long-term
survival models, have attracted the attention of an increasing number of researchers and
practitioners in survival analysis, as exemplified by the work of Maller & Zhou (1996),
Yakovlev & Tsodikov (1996), Ibrahim et al. (2001), Tsodikov et al. (2003), Nieto-Barajas
& Yin (2008), Yin (2008), and Kim et al. (2011), to name just a few. As in Zeng et al.
(2009), by allowing τ to be infinite, our general model encompasses cure rate models. The
argument can be seen as follows. We rewrite (2) as
, where Fk(y) = Hk(y)/Hk(τ) and β0k(τ) =
log{Hk(τ)}, so that Fk(·) acts like a cumulative distribution function (cdf). After integrating
out wi, the marginal survival function for the k-th event type is
. Under the piecewise baseline
hazard function, we have
Therefore, for each event type k and given x, the cure rate, denoted by ρk, is given by
(6)
where , meaning that the marginal survival
function is improper. The following proposition summarizes some properties of the cure
rate.
Proposition 1—The cure rate in (6) has the following properties:
i. The cure rates for the PH and PO models are ρk = {1 + θeβ0k(∞)+x′ βk}−θ
−1
 and ρk
= [1 + θ log{1 + eβ0k(∞)+x′ βk}]−θ
−1
, respectively.
ii. If λkj → ∞ for some j, then ρk → 0.
iii. If λkj → 0 for all j, then ρk → 1.
From (6), the proof of Proposition 1 is straightforward. In Proposition 1, (ii) and (iii) imply
that high (low) hazard ratios correspond to low (high) cure rates, as expected.
In the frequentist framework of Zeng et al. (2009), the estimator for Fk(·) is a cdf with jumps
only at the failure times. Nonparametric maximum likelihood estimation is carried out with
a constraint on the summation of the estimates of the density function. In our formulation,
we do not have this kind of constraint on the parameters of the piecewise hazard ratio
function.
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The exponential decay expression of the baseline hazard ratio function in the last interval of
each partition of the time axis implies that the cumulative baseline hazard function is
bounded. Thus, the survival function is improper, as seen above. On the other hand, if λkJk
→ ∞, the cumulative hazard function is unbounded and the survival function is proper. So,
under our approach, different from Yin (2008), we can deal with improper and proper
survival functions as well.
3 Prior and posterior
The Bayesian framework requires specification of a prior distribution for (β, λ, θ, r). We
postulate an improper joint prior distribution in which β, λ, θ and r are independent and β
has an improper uniform prior, so that
(7)
where θ and rk follow inverse gamma distributions (IG) with parameters (γ01, γ02) and (γ03k,
γ04k), respectively, and λkj ~ G(γ05kj, γ06kj), j = 1, …, Jk and k = 1, …, K. If γ05kj = γ06kj = 0,
we get a Jeffreys-type prior for λkj. The specification of an improper uniform prior for β is
commonly found in the literature. We specify the priors for θ and rk, k = 1, …, K, as inverse
gamma distributions. Since the frailty follows a gamma distribution in our model, this
choice facilitates the computational development in Appendix B. By combining (7) with the
likelihood function in (5), the posterior distribution based on the observed data is given by
(8)
Now, under very mild conditions, we provide a theorem characterizing the propriety of the
posterior distribution of (β, λ, θ, r) given the data Do.
Theorem 1
Consider the posterior distribution in (8) with γ05kj = γ06kj = 0 in the prior distribution (7), j
= 1, …, Jk − 1, k = 1, …, K. Let  be an n ×(p + Jk − 1) matrix with its i-th row equal to
. Assume that (i) when νik = 1, yik > 0, (ii)  is of full rank p
+ Jk − 1, k = 1, …, K, (iii) π(θ) is proper, i.e., γ01 > 0 and γ02 > 0, (iv) π(rk) is proper, i.e.,
γ03k > 0 and γ04k > 0, and (v) π(λkJk) is proper, i.e., γ05kJk > 0 and γ06kJk > 0, k = 1, …, K.
Then, the posterior distribution in (8) is proper.
The proof of Theorem 1 is given in Appendix A. If the prior distribution of λkj, j = 1, …, Jk
− 1, is proper, i.e., γ05kj > 0 and γ06kj > 0, the steps in the proof are similar. The conditions
(i) and (ii) require that all event times be strictly positive, at least one event occurs in each
chosen interval (sk,j−1, skj], and the design matrix X is of full rank. Such conditions are very
often satisfied and are quite easy to check.
In Appendix B, we provide the full conditional distributions needed to carry out the MCMC
simulations. The Gibbs sampler is based on the distribution (8), but to ease the
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computations, we resort to parameter transformations and introduction of latent variables, as
the reason for this is discussed in details in Appendix B.
4 A simulation study
In this section, we conduct a simulation study to compare the fits of the PH and
transformation models to data sets created under different conditions. Moreover, we also
assess some frequentist properties of the Bayesian model. In the data generation, we first
generate n independent xi2 ~ N (0, 1) and given xi2, we sample xi1 ~ Bernoulli(p(xi2)), where
p(xi2) = exp(0.5 + 0.3xi2)/{1 + exp(0.5 + 0.3xi2)}, i = 1, …, n. These values remain fixed
throughout the 500 repetitions of the simulations. The true values of the parameters are β11 =
1, β12 = −1.5, β21 = −0.5, β22 = 0.5, and θ = 0 or θ = 1. The failure times are generated from
(2) with Hk(y) = y, whereas the censoring variable has a uniform distribution on (0.5τ, 1.5τ)
with τ = 10. We chose K = 2 event types. The mean percentage of right censoring in the
simulations was about 10% and 26% for event types 1 and 2, respectively. The time
intervals for the piecewise baseline hazard functions are computed as described in Section
2.1. In (7), for the priors of θ, r, and λ, we put γ01 = γ02 = 0.1, γ03 = γ04 = 1, γ05kj = γ06kj = 0,
j = 1, …, Jk − 1, and γ05kJk = γ06kJk = 0.001, k = 1, 2. For these priors, both the mean and
variance do not exist. After discarding the first 2,000 iterations of the Gibbs sampler, from
the next 5,000 iterations, we took a spacing of size 5 leading to 1,000 samples for each
parameter.
We first compare the fitting of the proposed model to simulated data sets created under two
combinations of (r1, r2). There are many proposed methods for the comparison of models
fitted to a given data set and for selecting the one that best fits the data. Two commonly used
criteria are based on the Deviance Information Criterion (DIC) (Spiegelhalter et al., 2002)
and the Conditional Predictive Ordinate (CPO) (Ibrahim et al., 2001, Chapter 6). The DIC is
built upon the deviance D(ϑ) = −2 log{L(ϑ∣Do)}, where ϑ = (β′, λ′, θ, r′)′ and L(ϑ∣Do)
comes from (5). Using S samples ϑ1, …, ϑS from the Gibbs sampler output, the DIC is
computed as DIC = D(ϑ̄) + 2pD, where  and pD = D̄(ϑ) − D(ϑ̄) represents the
effective number of parameters, with . Given a set of candidate
models, the model yielding the smallest value of DIC is the one that best fits the data. For
each observation, CPOi can be approximated as ,
where Doi = (K, yi, xi, νi). An omnibus measure of fit based on the  is given by the
log-pseudomarginal likelihood (LPML) computed as . The larger
the value of LPML, the better the fit of the model.
In our simulation study, for each model used in the generation of the simulated data sets
(true model), we fit the PH, PO, and transformation models. The averages of LPML and
DIC over the 500 repetitions of the simulations, as well as the percentage of data sets in
which the true model was selected (correctness), are shown in Table 1. Since the baseline
hazard function is the same for both event types, we take the same number of intervals in the
partition of the time axes. Two values of θ (θ = 0 corresponds to the independence case) and
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two sample sizes were considered. When the PH model is the true one, the fit provided by
the PH model is better than the fit with the transformation model. Since the PH model is a
limiting case of the transformation model, this result is not unexpected. Since in these
simulations the results from the PO and transformation models are similar when PO is the
true model, correctness rates were computed by comparing the PO and PH models. The
results in Table 1 indicate that the data favor the transformation model over PO when PH is
the true model. When PO is the true model, PH yields the poorest fit, as expected, and the
differences between the PO and transformation models are remarkably small. Since PO
corresponds to a model in the interior of the parameter space, whereas PH is on the
boundary, this result is not surprising. For most of the cases, as expected, the correctness
rates increase with the sample size.
The second part of our simulation study involves point and interval estimation. The
transformation model was fitted. The results corresponding to (J1, J2) = (2, 2) intervals are
reported in Table 2. For both sample sizes the biases are small and, in general, the averages
of the posterior standard deviations (SD) are close to the root mean squared error of the
posterior means (RMSE). As expected, both SD and RMSE decrease with the sample size.
The coverage of the 95% highest posterior density (HPD) intervals lies between 91% and
97%. When θ = 0, the averages of the posterior means of θ are small for both sample sizes.
Moreover, the SD and RMSE of β are smaller. Taking into account that the transformation
parameters (r1, r2) are not kept fixed in our approach, these results suggest that the Bayesian
procedure has good properties since the posterior summaries in Table 2 are close to the
results of Zeng et al. (2009).
Additionally, we also fitted the three models under a misspecified frailty distribution. The
data were generated under the PO model and a lognormal frailty with mean = 1 and variance
= θ = 1. For the sake of space, the results are omitted here. As in Table 1, the DIC and
LPML provide good discrimination between the two models fitted with a wrong distribution
for the frailty (gamma distribution). When (J1, J2) = (5, 5), the correctness rates with (DIC,
LPML) are (96.8, 96.8) and (99.6, 99.8) for n = 200 and n = 400, respectively. With respect
to Table 2, the most remarkable differences are in the estimates of (r1, r2) and θ. Under the
misspecified frailty distribution and n = 400, the estimates of (r1, r2) are biased (with the
averages of the posterior means of 1.14 and 1.25, respectively) and have greater variability
than in Table 2. The large bias in the estimates of θ inflates its RMSE. The estimates of (β11,
β12, β21, β22) are unbiased.
5 Analysis of the transplant data
We apply the proposed methodology to a study of 859 patients receiving an umbilical cord
blood transplant for leukemia (AML, ALL, or CML) or myelodysplastic syndromes reported
in Ballen et al. (2012). According to the study protocol, the population consists of White,
African-American, Asian/Pacific Islander, and Hispanic patients with ALL, AML, MDS,
and CML who received unrelated umbilical cord blood transplants at U.S.A. transplant
centers and were reported to the CIBMTR between 1995 and 2006. Two events are
considered; namely, the time from transplant to first evidence of chronic graft-versus-host
disease (CGVHD) which occurred in 22.0% of the patients and the time from transplant to
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relapse or recurrence of the primary disease which occurred in 26.7% of the cases. These
events correspond to two complications of Hematopoietic Stem Cell Transplantation
(HSCT). The ranges of the failure times from transplant to CGVHD and to relapse are
0.093–3.035 and 0.002–9.893 years, respectively. For both the events, the censoring times
range from 0.003 to 12.41 years. In the dataset, 33 patients (3.8%) had both CGVHD and
leukemia relapse. Also, it is of clinical interest to know the likelihood that a patient will
never relapse or will never develop CGVHD. These are the “cure” fractions arising from a
cure model. Figure 1(a) displays the Kaplan-Meier estimates of the marginal survival
functions.
We consider the following covariates collected at the time of transplant: Disease (AML n =
33, ALL n = 361, CML n = 53, and MDS n = 100); disease status (early n = 252,
intermediate n = 386, advanced n = 211); patient age (range 0.27–78.21 years, mean 13.57,
sd=15); and recipient weight (range 5–181 kg, mean 37 kg, sd=26 kg). Our goal is to
identify risk factors for either or both of the event times. The transformation and PH models
were fitted to this data set. In (7), the priors of θ and λ are as in Section 4. For the
transformation model, we consider two types of priors for (r1, r2); namely, (1) moderate
prior: rk ~ IG(10, 10) and (2) informative prior: rk ~ IG(100, 100). With the vague prior
adopted in Section 4, we observed a lack of convergence of the MCMC chains for some
parameters. Results obtained with the PH model are also presented for the sake of
comparison. After discarding the first 10,000 iterations of the Gibbs sampler, we used
600,000 iterations with spacing of size 20, thus obtaining 30,000 samples for each
parameter. Convergence of the chains was monitored using graphical displays and the test
statistic proposed by Geweke (1992). In Table 3, we show the LPML and DIC values for
some combinations of the number of intervals. We point out that the transformation model
outperforms the PH model regardless of the number of intervals. When the number of
intervals increases, the two models yield a similar fit. However, when this number is small,
the fit from the transformation model is markedly better. For both models, the best fit is
obtained at (J1, J2) = (10, 25) intervals. With moderate priors for the transformation
parameters and (J1, J2) = (10, 25), Figure 1(b) displays the CPOi’s for the PH and
transformation models. We can see that there is support of the transformation model over the
PH model.
Table 4 displays some posterior summaries for the parameters with moderate priors for (r1,
r2). Under the transformation model, patients with ALL and CML are at the same risk level
as patients with AML (reference category for disease) for both time-to-relapse and time-to-
CGVHD. Patients having intermediate status disease at transplant are at the same risk level
as patients having early status disease (reference category) for both time-to-relapse and
time-to-CGVHD. Patients with MDS are at a lower risk level than patients with AML for
time-to-relapse. The difference between AML and MDS is not significant for time-to-
CGVHD. Older patients have higher risk for time-to-relapse. The effects of the recipient
weight at transplant on the risks are significant and in opposite directions. The point estimate
and the HPD interval for the frailty variance θ suggest a small variability in the frailty
variable. Posterior summaries for the bivariate PH model are also shown in Table 4. For
both event times, the estimates of most of the coefficients are smaller (in absolute value)
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under the PH model. While the effect of ALL is not significant under the transformation
model, by fitting the PH model, we see a significant effect on time-to-relapse. Since the best
fit is achieved with the transformation model, this point illustrates that the results from the
PH model can be misleading.
By plugging the posterior means of the parameters into (6), we obtain the estimates of the
cure rates for all patients. The dot plots of these estimates in Figure 2 highlight more
variability in the estimates for time-to-relapse. Since patients with advanced disease status at
transplant have a significantly higher risk for time-to-relapse, the cure rates for these
patients tend to be smaller, as depicted in Figure 2(a). Results from the transformation
model fitted with (J1, J2) = (5, 5) intervals show larger standard deviations than the entries
in Table 4 for all the parameters. There are also changes in the posterior mean estimates. For
example, the estimates of (r1, r2) jump from (1.731, 1.278) to (4.833, 3.480). To gain an
understanding of the role of the prior distributions for the transformation parameters in this
example, we fit a transformation model with (J1, J2) = (10, 25) intervals (best model in
Table 3) and IG(100, 100) priors for (r1, r2). For this model, DIC and LPML are equal to
1682.5 and -843.1, respectively, so that the differences do not seem to be important when
compared to the entries in Table 3.
In all the results reported thus far, for j = 1, …, Jk − 1 we chose the intervals (sk,j−1, sk,j] as
described in Section 2.1. With this setup, condition (ii) in Theorem 1 is satisfied and the
Gibbs sampler is stable. Of course, there are other constructions, such as intervals having
approximately equal lengths subject to the restriction that at least one failure occurs in each
interval. For this data set, most of the failures occur at earlier times (see Figure 1(a)), and
therefore such a construction does not seem to be sensible. Indeed, under this construction,
the fit is worse when compared to the DIC and LPML values in Table 3.
6 Concluding remarks
In this paper, we develop a Bayesian framework for inference in a general class of frailty
models for multivariate survival data. The commonly used proportional hazards and
proportional odds models arise as special cases of the logarithmic transformation in our
proposed transformation model. Although we mainly focus on the gamma frailty model, one
could entertain other types of frailty models as well as other types of censored data settings
and transformations. In Section 2, we can envision a more general model in which the some
event times may not be available for all the subjects. For example, if for a given subject i,
only the times yi2, …, yiK are observed, all we have to do is put yi1 = 0 and νi1 = 0.
Furthermore, we can extend our shared frailty model to a correlated frailty model. As stated
by Wienke (2011, Chapter 5), this class of models can be seen as a natural extension of the
shared frailty models. In a transformation correlated frailty model, identifiability and
efficient Bayesian computation constitute topics of interesting future research.
The interpretation of the regression parameter is an issue pervading transformation models.
Quoting Zeng & Lin (2007, p. 559): “we should not confine ourselves to a hazard
interpretation, especially when the hazards are not proportional and alternative formulations
DE CASTRO et al. Page 10






















lead to more parsimonious models.” When the proportionality of the hazards is not a
justifiable assumption, the meaning of the regression parameter is not so important.
We emphasize that in the papers by Yin (2008) and Zeng et al. (2009), the transformation
parameters in their multivariate models are fixed and model selection is based on some
criterion (for example, LPML, DIC, or likelihood function) computed over a grid of values
of the transformation parameters. These approaches pose questions on the choice of the grid
and on the extra variability due to the estimation of these parameters. In our approach, we
estimate the transformation parameters within a Bayesian framework, so that the variation
due to their estimation is accounted for. The results given in Sections 4 and 5 illustrate the
feasibility of our proposed model.
The dataset in our example has 859 observations from two event times and four covariates.
To obtain 50,000 samples from the posterior distribution, the computing time for the
transformation model in Table 3 with J1 = 10 and J2 = 25 was about 12 minutes. We ran the
program on an Intel i7 processor machine with 8 GB of RAM memory using a GNU/Linux
operating system. We believe that the program is scalable and is possible to fit the model to
datasets with hundreds of thousands of observations.
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(a) Kaplan-Meier estimates for the marginal survival functions (solid line: time to relapse,
dashed line: time to CGVHD) with tick marks representing the failure times (top side: time
to relapse, bottom side: time to CGVHD). (b) CPO plot for the bivariate PH and
transformation models with (J1, J2) = (10, 25) intervals and moderate priors for (r1, r2).
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Dot plots of the estimates of the cure rate according to the disease status under the bivariate
transformation model with (J1, J2) = (10, 25) intervals and moderate priors for (r1, r2). (a):
time-to-relapse and (b): time-to-CGVHD.
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